BioSpace News Archive

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its fourth quarter fiscal year 2020, ended March 31, 2020 , at 4:15pm Eastern time on Thursday , June 25, 2020. Management will host a conference call on Thursday

ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that the Company is set to join the Russell Microcap® Index at the conclusion of the 2020 Russell indexes annual reconstitution, effective after the US market opens on

Kronos Bio, Inc., dedicated to drugging transcriptional regulatory networks in cancer, today announced it has appointed Christopher Dinsmore, Ph.D., as Chief Scientific Officer. He will lead all aspects of the company’s discovery organization in Cambridge and will be responsible for advancing preclinical candidates targeting multiple oncogenic transcription regulatory networks. “Chris brings

New Health Intelligence™ service provides advanced molecular health markers and makes precise nutrition recommendations to improve health by integrating analysis of human, mitochondrial and gut microbial gene expressions.

Canopy Biosciences, a multi-omic CRO providing NanoString® nCounter® and RNA Seq services to both clinical and research customers, has partnered with OnRamp BioInformatics™ to offer their ROSALIND™ interactive data analysis platform for Canopy’s gene expression services. Launched earlier this year, Canopy has been providing this intuitive

Doximity, the professional medical network, has acquired THMED, a leading healthcare staffing solutions company

HALO Diagnostics released interim 10-year results from its Phase II 20-year clinical trial for prostate laser focal therapy in patients with localized prostate cancer. Over 170 men, 45-years or older diagnosed wi

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® has hired Vince DiMella as its U.S. Director of Sales and Ma

CardioFocus, Inc. today announced that the first U.S. patients have been treated commercially with the recently-approved HeartLight® X3 Endoscopic Ablation System

GreenLight Biosciences today announced it has raised an oversubscribed $102 million round of funding from new and existing investors to rapidly expand production of its RNA products for agricult